228 related articles for article (PubMed ID: 19108958)
1. Using hepatitis C virus and herpes simplex virus-2 to track HIV among injecting drug users in New York City.
Des Jarlais DC; Arasteh K; McKnight C; Hagan H; Perlman D; Friedman SR
Drug Alcohol Depend; 2009 Apr; 101(1-2):88-91. PubMed ID: 19108958
[TBL] [Abstract][Full Text] [Related]
2. Associations between herpes simplex virus type 2 and HCV With HIV among injecting drug users in New York City: the current importance of sexual transmission of HIV.
Des Jarlais DC; Arasteh K; McKnight C; Hagan H; Perlman DC; Semaan S
Am J Public Health; 2011 Jul; 101(7):1277-83. PubMed ID: 21566021
[TBL] [Abstract][Full Text] [Related]
3. Greater drug injecting risk for HIV, HBV, and HCV infection in a city where syringe exchange and pharmacy syringe distribution are illegal.
Neaigus A; Zhao M; Gyarmathy VA; Cisek L; Friedman SR; Baxter RC
J Urban Health; 2008 May; 85(3):309-22. PubMed ID: 18340537
[TBL] [Abstract][Full Text] [Related]
4. Decline in Herpes Simplex Virus Type 2 Among Non-Injecting Heroin and Cocaine Users in New York City, 2005 to 2014: Prospects for Avoiding a Resurgence of Human Immunodeficiency Virus.
Des Jarlais DC; Arasteh K; Feelemyer J; McKnight C; Tross S; Perlman DC; Campbell AN; Hagan H; Cooper HL
Sex Transm Dis; 2017 Feb; 44(2):85-90. PubMed ID: 27898577
[TBL] [Abstract][Full Text] [Related]
5. Reductions in hepatitis C virus and HIV infections among injecting drug users in New York City, 1990-2001.
Des Jarlais DC; Perlis T; Arasteh K; Torian LV; Hagan H; Beatrice S; Smith L; Wethers J; Milliken J; Mildvan D; Yancovitz S; Friedman SR
AIDS; 2005 Oct; 19 Suppl 3():S20-5. PubMed ID: 16251819
[TBL] [Abstract][Full Text] [Related]
6. HIV and hepatitis C virus risk in new and longer-term injecting drug users in Oslo, Norway.
Miller M; Mella I; Moi H; Eskild A
J Acquir Immune Defic Syndr; 2003 Jul; 33(3):373-9. PubMed ID: 12843749
[TBL] [Abstract][Full Text] [Related]
7. Hepatitis C virus prevalence and estimated incidence among new injectors during the opioid epidemic in New York City, 2000-2017: Protective effects of non-injecting drug use.
Des Jarlais DC; Arasteh K; Feelemyer J; McKnight C; Barnes DM; Perlman DC; Uuskula A; Cooper HLF; Tross S
Drug Alcohol Depend; 2018 Nov; 192():74-79. PubMed ID: 30243142
[TBL] [Abstract][Full Text] [Related]
8. Gender and age patterns in HSV-2 and HIV infection among non-injecting drug users in New York City.
Des Jarlais DC; Arasteh K; McKnight C; Perlman D; Hagan H; Semaan S; Friedman SR
Sex Transm Dis; 2010 Oct; 37(10):637-43. PubMed ID: 20838366
[TBL] [Abstract][Full Text] [Related]
9. Herpes simplex virus-2 and HIV among noninjecting drug users in New York city.
Des Jarlais DC; Hagan H; Arasteh K; McKnight C; Perlman D; Friedman SR
Sex Transm Dis; 2007 Nov; 34(11):923-7. PubMed ID: 18049425
[TBL] [Abstract][Full Text] [Related]
10. HSV-2 co-infection as a driver of HIV transmission among heterosexual non-injecting drug users in New York City.
Des Jarlais DC; Arasteh K; McKnight C; Perlman DC; Feelemyer J; Hagan H; Cooper HL
PLoS One; 2014; 9(1):e87993. PubMed ID: 24498235
[TBL] [Abstract][Full Text] [Related]
11. Alarming epidemics of human immunodeficiency virus and hepatitis C virus among injection drug users in the northwestern bordering state of Punjab, India: prevalence and correlates.
Panda S; Roy T; Pahari S; Mehraa J; Sharma N; Singh G; Singh J; Joseph F; Singh S; Sharma NM
Int J STD AIDS; 2014 Jul; 25(8):596-606. PubMed ID: 24352120
[TBL] [Abstract][Full Text] [Related]
12. Parallel declines in HIV and hepatitis C virus prevalence, but not in herpes simplex virus type 2 infection: A 10-year, serial cross-sectional study in an inner-city emergency department.
Patel EU; Laeyendecker O; Hsieh YH; Rothman RE; Kelen GD; Quinn TC
J Clin Virol; 2016 Jul; 80():93-7. PubMed ID: 27232485
[TBL] [Abstract][Full Text] [Related]
13. Improving survey methods in sero-epidemiological studies of injecting drug users: a case example of two cross sectional surveys in Serbia and Montenegro.
Judd A; Rhodes T; Johnston LG; Platt L; Andjelkovic V; Simić D; Mugosa B; Simić M; Zerjav S; Parry RP; Parry JV
BMC Infect Dis; 2009 Feb; 9():14. PubMed ID: 19203380
[TBL] [Abstract][Full Text] [Related]
14. "Informed altruism" and "partner restriction" in the reduction of HIV infection in injecting drug users entering detoxification treatment in New York City, 1990-2001.
Des Jarlais DC; Perlis T; Arasteh K; Hagan H; Milliken J; Braine N; Yancovitz S; Mildvan D; Perlman DC; Maslow C; Friedman SR
J Acquir Immune Defic Syndr; 2004 Feb; 35(2):158-66. PubMed ID: 14722449
[TBL] [Abstract][Full Text] [Related]
15. Continuity and change within an HIV epidemic. Injecting drug users in New York City, 1984 through 1992.
Des Jarlais DC; Friedman SR; Sotheran JL; Wenston J; Marmor M; Yancovitz SR; Frank B; Beatrice S; Mildvan D
JAMA; 1994 Jan; 271(2):121-7. PubMed ID: 8264066
[TBL] [Abstract][Full Text] [Related]
16. Prevalences and associated risk factors of HCV/HIV co-infection and HCV mono-infection among injecting drug users in a methadone maintenance treatment program in Taipei, Taiwan.
Yen YF; Yen MY; Su LW; Li LH; Chuang P; Jiang XR; Deng CY
BMC Public Health; 2012 Dec; 12():1066. PubMed ID: 23227904
[TBL] [Abstract][Full Text] [Related]
17. HIV among drug users at Beth Israel Medical Center, New York City, the first 25 years.
Des Jarlais DC; Arasteh K; Friedman SR
Subst Use Misuse; 2011; 46(2-3):131-9. PubMed ID: 21303233
[TBL] [Abstract][Full Text] [Related]
18. Prevalence and mapping of hepatitis C infections among men who have sex with men in New York City.
Tieu HV; Laeyendecker O; Nandi V; Rose R; Fernandez R; Lynch B; Hoover DR; Frye V; Koblin BA
PLoS One; 2018; 13(7):e0200269. PubMed ID: 30020960
[TBL] [Abstract][Full Text] [Related]
19. HCV infection prevalence lower than expected among 18-40-year-old injection drug users in San Diego, CA.
Garfein RS; Rondinelli A; Barnes RF; Cuevas J; Metzner M; Velasquez M; Rodriguez D; Reilly M; Xing J; Teshale EH
J Urban Health; 2013 Jun; 90(3):516-28. PubMed ID: 22766605
[TBL] [Abstract][Full Text] [Related]
20. Hepatitis C virus infection, HIV co-infection, and associated risk among injecting drug users in Togliatti, Russia.
Rhodes T; Platt L; Judd A; Mikhailova LA; Sarang A; Wallis N; Alpatova T; Hickman M; Parry JV
Int J STD AIDS; 2005 Nov; 16(11):749-54. PubMed ID: 16303071
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
